Ramkissoon, A; Chaney, KE; Milewski, D; Williams, KB; Williams, RL; Choi, K; Miller, A; Kalin, TV; Pressey, JG; Szabo, S; Azam, M; Largaespada, DA; Ratner, N. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK. Clinical Cancer Research. 2019; 25(13):clincanres.3224.2018-clincanres.3224.2018.

Zhang, L; He, X; Liu, X; Zhang, F; Huang, LF; Potter, AS; Xu, L; Zhou, W; Zheng, T; Luo, Z; Berry, KP; Pribnow, A; Smith, SM; Fuller, C; Jones, BV; Fouladi, M; Drissi, R; Yang, Z; Gustafson, WC; Remke, M; Pomeroy, SL; Girard, EJ; Olson, JM; Morrissy, AS; Vladoiu, MC; Zhang, J; Tian, W; Xin, M; Taylor, MD; Potter, SS; Roussel, MF; Weiss, WA; Lu, QR. Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse. Cancer Cell. 2019; 36(3):302-318.e7.

Melgar, K; Walker, MM; Jones, LM; Bolanos, LC; Hueneman, K; Wunderlich, M; Jiang, J; Wilson, KM; Zhang, X; Sutter, P; Wang, A; Xu, X; Choi, K; Tawa, G; Lorimer, D; Abendroth, J; O'Brien, E; Hoyt, SB; Berman, E; Famulare, CA; Mulloy, JC; Levine, RL; Perentesis, JP; Thomas, CJ; Starczynowski, DT. Overcoming adaptive therapy resistance in AML by targeting immune response pathways. Science Translational Medicine. 2019; 11(508):eaaw8828-eaaw8828.

Niss, O; Lane, A; Asnani, MR; Yee, ME; Raj, A; Creary, S; Fitzhugh, C; Bodas, P; Saraf, SL; Sarnaik, S; Devarajan, P; Malik, P. Progression of albuminuria in patients with sickle cell anemia: A multicenter, longitudinal study. Blood Advances. 2020; 4(7):1501-1511.

Muto, T; Walker, CS; Choi, K; Hueneman, K; Smith, MA; Gul, Z; Garcia-Manero, G; Ma, A; Zheng, Y; Starczynowski, DT. Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs. Nature Immunology. 2020; 21(5):535-545.